Max Healthcare
Indian private hospital network operating acute-care, super-specialty, diagnostic and home-health services.
Last updated August 25, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Max Healthcare is an Indian for-profit healthcare organization headquartered in New Delhi. Its principal business is the development and operation of private hospitals, particularly tertiary- and super-specialty facilities, with a network concentrated in northern India and additional operations in other major cities. The group also operates diagnostic and pathology services through Max Lab and home-based medical services through Max@Home. The business began in 2000 with a medical centre in Panchsheel Park, South Delhi. It expanded rapidly during the following decade, adding secondary-care centres in Pitampura and Noida, a flagship tertiary-care facility in Saket, and a hospital in Gurgaon. The organization subsequently built a broader Delhi National Capital Region network, including facilities in Shalimar Bagh, Vaishali, Patparganj and other locations. Its hospital portfolio has included services such as cardiology, oncology, neurosciences, renal medicine, transplant care, orthopaedics, gastroenterology, critical care and other complex specialties. Ownership and corporate structure changed substantially during the 2010s. South Africa's Life Healthcare Group acquired a minority interest in 2012 and increased it in 2014, becoming an equal joint-venture partner with Max India. Life Healthcare later announced its exit. In 2019, Radiant Lifecare acquired a substantial interest and Abhay Soi became chairman. The subsequent combination of Max Healthcare and Radiant Lifecare brought BLK Hospital in central Delhi and Nanavati Hospital in Mumbai into the enlarged group. Max Healthcare became publicly listed in August 2020. KKR was also involved as a co-promoter before selling its remaining interest during 2021–2022, after which Soi became the company's sole promoter with a stake exceeding 23 percent according to the cited reference material. The group has pursued expansion through acquisitions, hospital-development rights and operating agreements. It obtained rights connected with a proposed 500-bed Saket hospital, secured land for two Gurgaon hospitals, and agreed to operate the 300-bed Muthoot Hospital in Dwarka. It also acquired control of Eqova Healthcare, connected with a planned hospital in Patparganj. Acquisitions of Sahara Hospital in Lucknow, Alexis Multi-Specialty Hospital in Nagpur and a controlling interest in Jaypee Healthcare expanded its geographic reach. The later disposal of Jaypee's hospitals in Anupshahr and Bulandshahr indicated a preference for larger urban markets and super-specialty facilities. As of June 2025, the reference material describes Max Healthcare as operating 22 hospitals with more than 5,000 beds, primarily in North India. Its business model combines hospital care with diagnostics, home nursing, house calls, medicine delivery and related services. Through the Max Institute of Medical Excellence, the organization has also supported clinical training and medical education, including programs associated with overseas and UK-based institutions. The brand's positioning is therefore centered on organized private hospital care, advanced specialties, urban accessibility and an integrated care ecosystem rather than on a single medical product.
History
Max Healthcare opened its first medical centre in Panchsheel Park, South Delhi, in 2000. Its initial expansion used smaller secondary-care facilities, with centres in Pitampura and Noida opening in 2002. In 2004, the organization commissioned the East Block of Max Hospital, Saket, establishing a major tertiary-care base in South Delhi. A secondary-care hospital in Gurgaon followed in 2007. The group broadened its institutional footprint in 2011. It entered a public–private partnership with the Government of Punjab for hospitals in Mohali and Bathinda and commissioned a tertiary-care hospital in Shalimar Bagh. International ownership became important in 2012, when Life Healthcare Group acquired a 26 percent stake. Life Healthcare invested further in 2014, lifting its holding to 46.41 percent and becoming an equal joint-venture partner with Max India. In 2015, Max Healthcare acquired Pushpanjali Crosslay Hospital in Vaishali, Ghaziabad, and Saket City Hospital. These were later rebranded as Max Hospital Vaishali and Max Smart Hospital, Saket. The group added a standalone oncology facility, Max Cancer Centre in Lajpat Nagar, in 2016. Life Healthcare announced its intention to exit the joint venture in 2018. In 2019, Radiant Lifecare acquired a 49.7 percent interest for reported consideration of ₹2,136 crore, and Abhay Soi became chairman. The 2020 combination of Max Healthcare and Radiant Lifecare enlarged the network through the addition of BLK Hospital in Delhi and Nanavati Hospital in Mumbai. The combined organization was described in the reference material as India's second-largest healthcare company by revenue at that time. Max Healthcare listed on Indian stock exchanges in August 2020. KKR, which had been a co-promoter, sold its remaining interest during 2021 and 2022; Abhay Soi consequently became the sole promoter described in the reference material. Expansion after listing included both acquisitions and development arrangements. In 2021, Max Healthcare obtained rights connected with a proposed 500-bed Saket hospital, secured two Gurgaon land parcels and agreed to operate the 300-bed Muthoot Hospital in Dwarka. In 2022, it acquired a controlling stake in Eqova Healthcare, which held rights relating to medical services at a planned Patparganj hospital. The company acquired Sahara Hospital in Lucknow in December 2023 and Alexis Multi-Specialty Hospital in Nagpur in February 2024. In September 2024, it acquired 64 percent of Jaypee Healthcare at an enterprise value reported in the reference material as ₹1,660 crore. The transaction brought hospitals in Noida, Bulandshahr and Anupshahr under its control. In 2025, the company sold the Bulandshahr and Anupshahr facilities, signaling a focus on super-specialty hospitals in larger urban centres. Beyond hospitals, Max Healthcare has developed an integrated platform. Max Lab provides pathology and diagnostic testing through company-operated and partner facilities, while Max@Home offers home nursing, home healthcare, house calls and medicine delivery. Max Institute of Medical Excellence has supported professional training, including internal-medicine education associated with the Joint Royal College of Physicians Training Board in the United Kingdom and an MBBS-linked program associated with Lincoln American University in Guyana. As of June 2025, the reference material describes the group as operating 22 hospitals with more than 5,000 beds, primarily in North India.
- 2025
Portfolio concentrated on larger cities
[1]The company sold its hospitals in Anupshahr and Bulandshahr and stated a focus on larger urban super-specialty markets.
- 2024
Alexis and Jaypee expansion
[1]Max Healthcare acquired Alexis Multi-Specialty Hospital and a controlling stake in Jaypee Healthcare.
- 2023
Sahara Hospital acquired
[1]The group acquired Sahara Hospital in Lucknow.
- 2020
Merger and stock-market listing
[1]Max Healthcare combined with Radiant Lifecare and listed in August.
- 2019
Radiant Lifecare investment
[1]Radiant Lifecare acquired a substantial stake and Abhay Soi became chairman.
- 2015
Vaishali and Saket acquisitions
[1]Pushpanjali Crosslay Hospital and Saket City Hospital were acquired and later rebranded.
- 2012
Life Healthcare became an investor
[1]Life Healthcare Group acquired a minority stake.
- 2011
Punjab partnership and Shalimar Bagh hospital
[1]The group entered a Punjab public–private partnership and commissioned its Shalimar Bagh tertiary-care hospital.
- 2004
Saket tertiary hospital commissioned
[1]The East Block of Max Hospital, Saket, began operations.
- 2002
Secondary-care expansion
[1]The company opened additional centres in Pitampura and Noida.
Products and positioning
An urban Indian private healthcare network focused on tertiary and super-specialty hospital care, supported by diagnostics, home healthcare and professional education.
Hospital network · 2000
Max Super Speciality Hospitals
The core hospital network provides inpatient, outpatient, emergency, critical-care and advanced specialty treatment. Facilities serve major urban markets and cover disciplines including oncology, cardiology, neurosciences, renal medicine, transplant care, orthopaedics and gastroenterology.
Diagnostics and pathology
Max Lab
Max Lab provides pathology and diagnostic testing through its own laboratories and partner entities. It extends the brand beyond hospital-based treatment and supports testing for outpatient, inpatient and referring-clinician needs.
Home healthcare
Max@Home
Max@Home delivers medical support outside hospital facilities, including home nursing, home-health services, house calls and medicine delivery. The division is intended to connect hospital-based care with recovery and ongoing support at home.
Medical education
Max Institute of Medical Excellence
The institute organizes clinical education and training across multiple disciplines. Its activities described in the reference material include internal-medicine training associated with the Joint Royal College of Physicians Training Board and an MBBS-linked clinical-rotation program associated with Lincoln American University.
Controversies
2020
COVID-19 treatment-price criticism
During the COVID-19 outbreak, the Patparganj hospital faced criticism over reported daily treatment costs. The hospital responded that charges above ₹1 lakh per day applied only to very critical patients.
2017
Shalimar Bagh newborn-death declaration
Authorities suspended the license of Max Super Speciality Hospital, Shalimar Bagh, after a premature baby was incorrectly declared dead and was subsequently found alive. The suspension was stayed later in the month and the hospital resumed operations.
2016
Dispute over free-treatment obligations
The Delhi government included Max Super Speciality Hospital, Saket, among hospitals accused of failing to provide the required proportion of free treatment to economically disadvantaged patients under conditions associated with concessional land.
2015
Competition investigation into syringe pricing
The Competition Commission of India investigated allegations that the Patparganj hospital required patients to buy disposable syringes from its pharmacy at inflated prices. The investigation concluded in 2017 that the hospital had earned margins described as ranging from 275 percent to 525 percent and characterized the conduct as abuse of a dominant position.
2013
Mohali pacemaker negligence case
After a patient died following pacemaker implantation at Max Super Speciality Hospital, Mohali, allegations were made that an inappropriate or low-cost device had been implanted. A court later summoned the hospital's chief executive and the doctor on allegations including negligence, conspiracy and cheating. In 2017, a consumer commission ordered compensation of ₹32.94 lakh to the patient's widow, and the Punjab and Haryana High Court upheld the summoning order in 2024.
Brand decisions
2025
Concentrate on larger-city super-specialty hospitalsStrategyBackground
After acquiring control of Jaypee Healthcare, Max Healthcare reassessed the fit of smaller-market facilities within its portfolio.
Action taken
The company sold the hospitals in Anupshahr and Bulandshahr.
Aftermath
The divestments reinforced a strategy focused on super-specialty hospitals in larger cities.
Reported sale consideration. ₹40 crore (2025)
2024
Acquire Alexis and Jaypee interestsM&ABackground
The company continued expanding through facilities in major regional markets and through control of an existing hospital platform.
Action taken
Max Healthcare acquired Alexis Multi-Specialty Hospital in Nagpur and a 64 percent stake in Jaypee Healthcare.
Aftermath
The transactions expanded the network into Nagpur and added hospitals in Noida, Bulandshahr and Anupshahr before later portfolio rationalization.
Reported Jaypee Healthcare enterprise value. ₹1,660 crore (September 2024)
2023
Acquire Sahara HospitalM&ABackground
Max Healthcare sought to extend its network into additional large Indian cities.
Action taken
The company acquired Sahara Hospital in Lucknow.
Aftermath
The transaction added a major hospital operation in Uttar Pradesh.
Reported acquisition consideration. ₹940 crore (December 2023)
2022
Acquire control of Eqova HealthcareM&ABackground
Eqova Healthcare held rights connected with medical services for an upcoming hospital in Patparganj.
Action taken
Max Healthcare acquired a controlling stake in Eqova Healthcare.
Aftermath
The transaction strengthened the group's pipeline in East Delhi.
2021
Build and operate additional Delhi-NCR capacityStrategyBackground
The company sought to expand beyond its existing Delhi hospitals while retaining a strong urban-market focus.
Action taken
It obtained rights connected with a proposed 500-bed Saket hospital, secured two Gurgaon land parcels and agreed to manage the 300-bed Muthoot Hospital in Dwarka.
Aftermath
The arrangements increased the group's development pipeline and operating footprint without relying solely on completed-hospital acquisitions.
2020
List on Indian stock exchangesOtherBackground
Following its combination with Radiant Lifecare, the company pursued public-market access.
Action taken
Max Healthcare listed on Indian stock exchanges in August 2020.
Aftermath
The listing provided a public corporate structure for subsequent expansion and promoter-ownership changes.
2019
Combine with Radiant LifecareM&ABackground
Radiant Lifecare acquired a 49.7 percent stake after Life Healthcare decided to exit the joint venture.
Action taken
Max Healthcare merged with Radiant Lifecare, bringing BLK Hospital in Delhi and Nanavati Hospital in Mumbai into the enlarged organization.
Aftermath
The combination created a substantially larger hospital platform and preceded the company's 2020 public listing.
Recent events
- 2025
Max Healthcare sold two smaller Jaypee hospitals[1]
M&A
The company sold its hospitals in Anupshahr and Bulandshahr as it emphasized super-specialty hospitals in larger cities.
- 2024
Max Healthcare acquired Alexis Multi-Specialty Hospital[1]
M&A
The acquisition of Alexis Multi-Specialty Hospital expanded the network into Nagpur.
- 2024
Max Healthcare acquired control of Jaypee Healthcare[1]
M&A
Max Healthcare acquired a 64 percent stake in Jaypee Healthcare, gaining control of hospitals in Noida, Bulandshahr and Anupshahr.
- 2023
Max Healthcare acquired Sahara Hospital in Lucknow[1]
M&A
The group expanded into Lucknow through the acquisition of Sahara Hospital.
- 2020
Max Healthcare became publicly listed[1]
Other
The company completed its stock-market listing in August 2020.
- 2019
Radiant Lifecare acquired a major stake in Max Healthcare[1]
M&A · Leadership change
Radiant Lifecare acquired a 49.7 percent interest, and Abhay Soi became chairman.
- 2015
Max Healthcare acquired Pushpanjali Crosslay and Saket City Hospital[1]
M&A
The acquisitions added hospitals later branded as Max Hospital Vaishali and Max Smart Hospital, Saket.
- 2014
Life Healthcare increased its stake and became an equal joint-venture partner[1]
M&A
Life Healthcare made a further investment, increasing its holding to 46.41 percent and becoming an equal joint-venture partner with Max India.
- 2012
Life Healthcare acquired a minority stake in Max Healthcare[1]
M&A
Life Healthcare Group acquired a 26 percent interest in Max Healthcare for reported consideration of ₹516 crore.
Sources4 sources
- 1Max Healthcareen.wikipedia.org
- 2Max Healthcare official websitemaxhealthcare.in
- 3Max Healthcare acquires rights to develop, provide medi services to proposed hospital in Delhibusiness-standard.com
- 4Max India Limited reports strong Q3FY2020 financial results; Max Healthcare's EBITDA of Rs 121 Crore, grows 92 percentbusiness-standard.com
Cite this profile: Cite the canonical profile. /brand-wiki/max-healthcare · Editorial policy · How profiles are compiled